Estrogen-mimicking compounds in foods may reduce effectiveness of breast cancer treatment
New TSRI study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogensScientists from The Scripps Research Institute (TSRI) have discovered that two estrogen-mimicking compounds found in many foods appear to potently reverse the effects of palbociclib/letrozole, a popular drug combination…
A more complete Mediterranean diet may protect against aggressive prostate cancer
New study in The Journal of Urology® finds that a high intake of fruits, vegetables, and whole grains might not be enough In a new study published in The Journal of Urology®, researchers determined that men who followed a Mediterranean diet, rich in fish, boiled…
Fast food makes the immune system more aggressive in the long term
The immune system reacts similarly to a high fat and high calorie diet as to a bacterial infection. This is shown by a recent study led by the University of Bonn. Particularly disturbing: Unhealthy food seems to make the body’s defenses more aggressive in the…
A kiss of death for prostate cancer
Hokkaido University researchers have uncovered a cellular protein that stabilizes a tumor promoting signaling pathway, suggesting a new target to treat prostate cancer.
Cervical cancer diagnoses and deaths to rocket in older women
Incidence of cervical cancer in young women is set to decline 75 per cent by 2040 with deaths close to eradicated, however older women will face greater risk according to research led by Queen Mary University of London, published today in The Lancet Public Health.
Active Surveillance of Low-Risk Papillary Microcarcinoma of the Thyroid Proposed as First-Line Management
A 10-year study of more than 1,200 patients with low-risk papillary microcarcinoma (PMC) of the thyroid led researchers to conclude that close and continuous monitoring is an acceptable first-line approach to patient management instead of immediate surgery to remove the tumor.
Postmenopausal breast cancer: It is sufficient to extend treatment by two years
Standard treatment for postmenopausal breast cancer is to give a hormonal breast cancer drug for 5 years following surgical removal of the tumour.
Worldwide, nearly 6% of cancers are attributable to diabetes and high BMI
Diabetes and high BMI (a BMI over 25 kg/m2) were the cause of 5.6% of new cancer cases worldwide in 2012 – equivalent to 792600 cases, according to the first study to quantify the proportion of cancers attributable to diabetes and high BMI published in…
Fertility preservation with hormone stimulation did not increase risk of breast cancer relapse
Women who received hormone stimulation for fertility preservation did not have a higher relapse rate in breast cancer compared with unexposed control women in a study from Karolinska Institutet in Sweden published in Breast Cancer Research and Treatment. The results could influence the clinical practice…
Can Cannabinoids Be Used to Treat Cancer?
When cannabinoids activate signaling pathways in cancer cells they can stimulate a cell death mechanism called apoptosis, unleashing a potent anti-tumor effect. Yet cannabinoids, which have also shown strong activity against human tumor tissue grown in animal models, have undergone minimal testing in patients.
Palliative care in neurology helps patients and their caregivers
“The significance of palliative care extends far beyond ‘end-of-life treatment’ for cancer patients,” Secretary General of the World Federation of Neurology (WFN) Prof Wolfgang Grisold emphasizes at the occasion of XXIII World Congress for Neurology in Kyoto. There are a number of important areas for…
Abdominal fat a key cancer driver for postmenopausal women
Body fat distribution in the trunk is more important than body weight when it comes to cancer risk in postmenopausal women, according to a study presented at the ESMO 2017 Congress in Madrid.